Skip to main content

Table 2 Covariates and RRM1 or ERCC1 (Patient N, row%)

From: Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?

 

RRM1 Expression

ERCC1 Expression

 

RRM1 mRNA expression (PCR)

  

RRM1 protein expression (IHC)

  

ERCC1 mRNA expression (PCR)

  

ERCC1 protein expression (IHC)

  

Covariate

High

Low

N

p

High

Low

N

p

High

Low

N

p

High

Low

N

p

Age (years)

                

Young (<65.5)

4 (21%)

15 (79%)

49

1.0

14 (30%)

32 (70%)

93

0.51

19 (48%)

21 (53%)

79

0.36

29 (62%)

18 (38%)

94

0.41

Old (> 65.5)

6 (20%)

24 (80%)

  

18 (38%)

29 (62%)

  

14 (36%)

25 (64%)

  

24 (51%)

23 (49%)

  

Size (cm)

                

Small (<2.0)

1 (9%)

10 (91%)

49

0.42

5 (26%)

14 (74%)

93

0.59

4 (31%)

9 (69%)

79

0.54

11 (55%)

9 (45%)

94

1.0

Large (> 2.0)

9 (24%)

29 (76%)

  

27 (36%)

47 (64%)

  

29 (44%)

37 (56%)

  

42 (57%)

32 (43%)

  

Gender

                

Female

6 (24%)

19 (76%)

49

0.73

14 (35%)

26 (65%)

93

1.0

13 (37%)

22 (63%)

79

0.50

25 (61%)

16 (39%)

94

0.53

Male

4 (17%)

20 (83%)

  

18 (34%)

35 (66%)

  

20 (45%)

24 (55%)

  

28 (53%)

25 (47%)

  

Race

                

White

4 (12%)

29 (88%)

48

0.11

23 (35%)

43 (65%)

92

1.0

22 (42%)

31 (58%)

78

1.0

36 (55%)

30 (45%)

93

0.82

Non-White

5 (33%)

10 (67%)

  

9 (35%)

17 (65%)

  

11 (44%)

14 (56%)

  

16 (59%)

11 (41%)

  

Histological Grade¥

                

1 or 2

7 (19%)

29 (81%)

48

1.0

22 (30%)

51 (70%)

92

0.10

27 (45%)

33 (55%)

78

0.43

42 (57%)

32 (43%)

93

0.80

3 or 4

2 (17%)

10 (83%)

  

10 (53%)

9 (47%)

  

6 (33%)

12 (67%)

  

10 (53%)

9 (47%)

  

Lymph Nodes¥

                

No LN positive

4 (31%)

9 (69%)

47

0.24

9 (35%)

17 (65%)

91

1.0

14 (64%)

8 (36%)

77

0.024

16 (59%)

11 (41%)

92

0.82

At least 1 LN positive

5 (15%)

29 (85%)

  

23 (35%)

42 (65%)

  

19 (35%)

36 (65%)

  

36 (55%)

29 (45%)

  

Depth of Tumor (pT) ¥

                

T1 and T2

2 (20%)

8 (80%)

48

1.0

4 (27%)

11 (73%)

92

0.56

4 (36%)

7 (64%)

78

0.75

5 (33%)

10 (67%)

93

0.087

T3 and T4

7 (18%)

31 (82%)

  

28 (36%)

49 (64%)

  

29 (43%)

38 (57%)

  

47 (60%)

31 (40%)

  
  1. ¥ The difference in values corresponds to the patients with metastatic disease only, for whom some variables were not able to be computed.